Advancing Hepatitis C Screening: Insights from AST Pesaro-Urbino’s First-Year Results
Hepatitis C Virus (HCV) remains a major public health concern, leading to chronic liver disease and severe complications if left untreated. In 2016, the World Health Organization (WHO) launched a global initiative to eliminate HCV by 2030. As part of this effort, Italy implemented a nationwide screening program, targeting individuals born between 1969 and 1989. A recent study conducted at AST Pesaro-Urbino in the Marche region provides valuable insights into the program’s effectiveness. A recent study titled " Evaluation of Screening Program for Hepatitis C Virus (HCV) At AST Pesaro-Urbino: First Year Results" published in the Journal of Biomedical Research & Environmental Sciences (JBRES).
Key Findings from
the Study
๐น Screening Coverage
Between August 2023 and July 2024, six blood collection centers screened 6,319
individuals, representing 12.4% of the target population.
๐น Prevalence of HCV
Among those screened, 64 individuals (1%) tested positive for anti-HCV
antibodies, and 8 (0.13%) were confirmed to have active HCV infections.
๐น Gender-Based Trends
Despite a higher participation rate among females (59.2% vs. 40.8% males), the
positivity rate was higher in males.
๐น Public Health Impact
The low prevalence of active infections suggests that prior public health
interventions and antiviral treatments have been effective in reducing HCV
cases.
Implications for
Future Research & Screening Strategies
The study underscores the importance
of continued screening efforts to identify undiagnosed HCV cases and prevent
transmission. Expanding the screening program to include individuals born
before 1969 and improving outreach strategies could enhance early detection and
treatment.
For a detailed analysis, you can
read the full research article here:
๐ Read
Full Article
Call for Papers –
Journal of Biomedical Research & Environmental Sciences (JBRES)
At the Journal of Biomedical Research & Environmental Sciences (JBRES), we invite
high-quality submissions related to:
- Epidemiology and public health strategies for viral
infections
- Advances in HCV diagnosis and treatment
- Molecular biology of infectious diseases
- Healthcare policies and disease prevention programs
We are currently accepting
submissions for our upcoming issue! If your research aligns with these topics,
we encourage you to submit your manuscript today.
๐
Submission Deadline: February 25, 2025.
๐ฉ Submit Your Manuscript Here:
๐ Submit
Now
For more details, visit our journal
website:
๐ JBRES Official
Website
๐ง For inquiries, contact us at:
bridget.j@scireslit.us | bridgetjones.srl@gmail.com
Join us in advancing scientific
research and contributing to global health efforts! ๐
#HepatitisCScreening
#BiomedicalResearch #PublicHealth #HCVElimination #Epidemiology #CallForPapers
#SubmitYourResearch #JBRES
Comments
Post a Comment